Buyer landscape
Likely buyers · Biotech in Belgium.
Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables
How companies like this sold · 22 verified exits: 14% to sponsors, 68% to corporates and platforms, 18% via IPO. Route shift since 2020: sponsors 23% (was 30%), corporates and platforms 67% (was 54%), IPO 8% (was 15%) (sector-wide).
The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 13 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.
Financial buyers · 24
Tier 1 · Very High · score 70+
1. Bpifrance Investissement SponsorVery High80
10 platform investments in Healthcare · 35 deals 2024–26
AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M
Accelerating: 30 deals in the last 2 years vs 4.5/yr before.
Backed Adcendo, 2026 · Biotech, Denmark
2. Novo Holdings SponsorVery High79
114 platform investments in Healthcare · 1 in Belgium · 43 deals 2024–26
AUM €93.0B · Novo Holdings Bioindustrial Investments · 1999 vintage · no newer fund
142 platform investments since the 1999 vintage · largely deployed vs its usual 24 per fund.
Backed cAMPfield, 2026 · Biotech, US
3. ArchiMed SponsorVery High78
56 platform investments in Healthcare · 1 in Belgium · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
4. Archimedes Partners SponsorVery High78
53 platform investments in Healthcare · 1 in Belgium · 21 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
5. Merieux Equity Partners / Vitruvian Partners SponsorVery High78
57 platform investments in Healthcare · 6 in Belgium · 6 deals 2024–26
AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M
2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.
Backed Ona Therapeutics, 2026 · Biotech, Spain
6. Apheon SponsorVery High78
11 platform investments in Healthcare · 14 in Belgium · 11 deals 2024–26
AUM €4.5B · AMB VI · 2025 vintage · deploying · check €25-188M
7 platform investments since the 2025 vintage · largely deployed vs its usual 6 per fund.
Backed Teknimed, 2026 · MedTech, France
7. Apheon TMC HDC Long Term Value Fund (HarbourVest-led) + LFPI SponsorVery High78
11 platform investments in Healthcare · 14 in Belgium · 12 deals 2024–26
AUM €4.5B · AMB VI · 2025 vintage · deploying · check €25-188M
7 platform investments since the 2025 vintage · largely deployed vs its usual 6 per fund.
Backed Teknimed, 2026 · MedTech, France
8. Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + LFPI-backed continuation fund) SponsorVery High78
11 platform investments in Healthcare · 14 in Belgium · 12 deals 2024–26
AUM €4.5B · AMB VI · 2025 vintage · deploying · check €25-188M
7 platform investments since the 2025 vintage · largely deployed vs its usual 6 per fund.
Backed Teknimed, 2026 · MedTech, France
9. Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + MML Capital-backed continuation fund) SponsorVery High78
11 platform investments in Healthcare · 14 in Belgium · 12 deals 2024–26
AUM €4.5B · AMB VI · 2025 vintage · deploying · check €25-188M
7 platform investments since the 2025 vintage · largely deployed vs its usual 6 per fund.
Backed Teknimed, 2026 · MedTech, France
10. ARCHIMED and Institut Mérieux SponsorVery High78
54 platform investments in Healthcare · 1 in Belgium · 19 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
11. ArchiMed and Tethys Invest SponsorVery High78
54 platform investments in Healthcare · 1 in Belgium · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
12. Inflexion SponsorVery High77
10 platform investments in Healthcare · 1 in Belgium · 27 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.
Bought Primed from Paragon Partners, 2026 · MedTech, Germany
14. IK Partners SponsorVery High76
34 platform investments in Healthcare · 8 in Belgium · 52 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Bought Biobank from Bpifrance Investissement, 2024 · Biotech, France
15. Ring Capital SponsorVery High76
10 platform investments in Healthcare · 2 in Belgium · 32 deals 2024–26
AUM €470M · Ring Altitude II · 2025 vintage · deploying · check €4-33M
17 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Exapto, 2024 · Biotech, France
16. NORD Holding SponsorVery High76
15 platform investments in Healthcare · 15 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 13 deals in the last 2 years vs 2.5/yr before.
Bought Hallmarq Veterinary Imaging from August Equity, 2026 · MedTech, UK
17. Lauxera Capital Partners SponsorVery High76
16 platform investments in Healthcare · 6 deals 2024–26
AUM €780M · Lauxera Growth II · 2025 vintage · deploying · check €10-78M
3 platform investments since the 2025 vintage · early in deployment vs its usual 8 per fund.
Backed GenePlanet, 2026 · Biotech, Slovenia
18. Turenne Groupe SponsorVery High75
55 platform investments in Healthcare · 3 in Belgium · 34 deals 2024–26
AUM €2.0B · Capital Sante 3 · 2025 vintage · deploying · check €3-21M
20 platform investments since the 2025 vintage · early in deployment vs its usual 80 per fund.
Backed Mablink, 2021 · Biotech, France
19. PAI Partners SponsorVery High75
24 platform investments in Healthcare · 5 in Belgium · 26 deals 2024–26
AUM €33.0B · PAI Mid-Market Fund II · 2025 vintage · deploying
12 platform investments since the 2025 vintage · largely deployed vs its usual 10 per fund.
Bought Nuzoa from Abac Capital, 2025 · Pharma, Spain
20. Inflexion (Partnership Capital III) SponsorVery High75
9 platform investments in Healthcare · 1 in Belgium · 25 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
Accelerating: 15 deals in the last 2 years vs 5.0/yr before.
Backed Primed, 2026 · MedTech, Germany
21. NORD Holding / Pinova Capital SponsorVery High75
12 platform investments in Healthcare · 12 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 10 deals in the last 2 years vs 2.5/yr before.
Backed Hallmarq Veterinary Imaging, 2026 · MedTech, UK
22. Audacia SponsorVery High74
9 platform investments in Healthcare · 27 deals 2024–26
AUM €2.8B · Audacia Capital Développement IV · 2023 vintage · deploying · check €4-30M
45 platform investments since the 2023 vintage · largely deployed vs its usual 12 per fund.
Backed Biomemory, 2025 · Biotech, France
23. bm-t Beteiligungsmanagement Thueringen SponsorVery High74
13 platform investments in Healthcare · 13 deals 2024–26
AUM €465M · Mittelstands-Fonds Thueringen II (MFT II) · 2025 vintage · deploying · check €0-3M
Accelerating: 8 deals in the last 2 years vs 2.5/yr before.
Backed Applyo Jena, 2025 · Biotech, Germany
24. Impact Expansion Management SponsorVery High74
5 platform investments in Healthcare · 4 in Belgium · 10 deals 2024–26
AUM €150M · Impact Expansion Fund I · 2024 vintage · deploying · check €3-23M
10 platform investments since the 2024 vintage · largely deployed vs its usual 8 per fund.
Backed neurocare, 2025 · HealthTech, Germany
25. EQT SponsorVery High73
50 platform investments in Healthcare · 5 in Belgium · 51 deals 2024–26
AUM €291.0B · EQT X · 2023 vintage · deploying · check €440M-3.3B
53 platform investments since the 2023 vintage · largely deployed vs its usual 11 per fund.
Backed Aldevron, 2019 · Biotech, US
Strategic buyers · 1
Tier 1 · Very High · score 70+
13. Gilead Sciences CorporateVery High77
6 acquisitions in Healthcare · 4 deals 2024–26
Accelerating: 4 deals in the last 2 years vs 0.3/yr before.
Bought Tubulis from Athos, 2026 · Biotech, Germany
Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.